Jan 10, 2024 / 11:45PM GMT
Tessa Romero J.P. Morgan-Analyst
Welcome everyone to the 42nd Annual JPMorgan Health. My name is Tessa Romero, and I am one of the senior biotech analysts here at JPMorgan. Presenting company is Gen generation's style and speeding up the Company XCEO.
Geoff Mcdonough Generation Bio Co.-CEO
Thank you tests for that kind introduction, and thank you for being here, and thank you for the chance to share with you the significant progress that we're making with generation Bio. We are genetic medicines company, and I'm particularly excited to be here today because I'm going to share a very significant set of advancements in our two platforms that have resulted in a pretty meaningful shift in our overall portfolio strategy. So you can say you were here when we told you where we're headed I'd remind you of a few forward looking statements about the company which is public, and please refer to this statement in your leisure time.
And we'll take time to read it today at a summary level, we have made very significant progress with two breakthrough
Generation Bio Co at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers